Skip to main content

Advertisement

SpringerLink
Log in

Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx

  • Head and Neck Oncology
  • Published:
European Archives of Oto-Rhino-Laryngology and Head & Neck Aims and scope Submit manuscript

Abstract

Cyclin D1 is one of the key proteins involved in cell cycle control, and it is believed that its overexpression may be connected with tumorigenesis. A reason for cyclin D1 deregulation may be connected to a common G870A polymorphism at codon 242 in exon 4 of the CCND1 gene. This single nucleotide substitution, localized in the conserved splice donor site between exon 4 and the intron 4 boundary, might modulate the frequency of alternative splicing. It has been postulated that the A allele results in a higher level of mRNA (transcript b) encoding a protein with an altered C-terminal domain. The influence of CCND1 G→A polymorphism for the risk of cancer and the prognosis of patients with different types of solid tumors has already been suggested. This study was conducted to investigate the association between the cyclin D1 gene polymorphism and laryngeal cancer risk, as well as the clinical outcome. We also examined the relationship between genotype/allele distributions and the cyclin D1 expression profile. The genotyping study was done using the PCR-RFLP method in 63 patients with larynx cancer and 102 healthy controls. The heterozygotic genotype GA as well as a combination of GA and AA genotypes were associated with an increased risk of larynx cancer compared to the GG genotype (OR =3.02; P =0.004 and OR =2.52; P =0.013, respectively). The A allele frequency was higher in cancer cases (0.484) than in controls (0.416) that were connected with a slightly increased risk of cancer development (OR =1.34); however, the difference was not significant. The AA genotype was associated with an early cancer onset compared to the GG genotype (median age: 51.5 and 63.0 years, respectively). We also demonstrated that the AA genotype was associated with the occurrence of lymph node metastases (OR =3.26) and a higher level of cyclin D1 overexpression. These results suggest that the CCND1 A allele may be a genetic factor that modulates the risk of larynx cancer development, and it may also have an effect on tumor biology and disease prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akervall A, Michalides R, Mineta H, Balm A, Borg A, Dictor M, Jin Y, Loftus B, Martens F, Wennerberg J (1997) Amplification of cyclin D1 in squamous cell carcinoma of he head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79:380–389

    Article  PubMed  Google Scholar 

  2. Akervall A, Borg A, Dictor M, Ji C, Jin Y, Tanner M, Isola J, Martens F, Wennerberg J (2002) Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol 20:45–52

    PubMed  Google Scholar 

  3. Bartkova J, Lukas J, Bartek J (1997) Aberrations of the G1- and G1/S-regulating genes in human cancer. Prog Cell Cycle Res 3:211–220

    PubMed  Google Scholar 

  4. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, Scambia G, Neri G (1996) Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2:175–180

    PubMed  Google Scholar 

  5. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder W, Heighway J (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11:1005–1011

    PubMed  Google Scholar 

  6. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG (1994) Prad-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74:152–158

    PubMed  Google Scholar 

  7. de Boer CJ, Loyson S, Kluin PM, Kluion-Neleman HC, Schuuring E, van Krieken JH (1993) Multiple breakpoints with the bcl-1 locus in B-cell lymphoma: rearrangement of the cyclin D1 gene. Cancer Res 6:4148–4152

    Google Scholar 

  8. Diehl JA (2002) Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226–231

    PubMed  Google Scholar 

  9. Diehl JA, Zindy F, Sherr CJ (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 11:957–972

    PubMed  Google Scholar 

  10. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499–3511

    PubMed  Google Scholar 

  11. Donnellan R, Chetty R (1998) Cyclin D1 and human neoplasia (reviews). Mol Pathol 51:1–7

    PubMed  Google Scholar 

  12. Dowdy S, Hinds P, Louie K, Reed S, Arnold A, Weinberg R (1992) Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499–411

    Article  Google Scholar 

  13. Gleich LL, Salamone FN (2002) Molecular genetics of head and neck cancer. Cancer Control 9:369–378

    PubMed  Google Scholar 

  14. Holley SL, Parkes G, Matthias C, Bockmuhl U, Jahnke V, Leder K, Strange RC, Fryer AA, Hoban PR (2001) Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159:1917–1924

    PubMed  Google Scholar 

  15. Hosokawa Y, Tu T, Tahara H, Smith AP, Arnold A (1995) Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism. Cancer Lett 93:165–170

    Article  PubMed  Google Scholar 

  16. Izzo JG, Papadimitrakopoulou VA, Liu DD, den Hollander PL, Babenko IM, Keck J, El-Naggar AK, Shin DM, Lee JJ, Hong WK, Hittelman WN (2003) Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst 95:198–205

    PubMed  Google Scholar 

  17. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Trassera J, Cardesa A (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54:4813–4817

    PubMed  Google Scholar 

  18. Kong S, Wei Q, Amos CI (2001) Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 93:1106–1108

    Article  PubMed  Google Scholar 

  19. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J, Jones PW, Strange RC, Fryer AA, Hoban P (1998) Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 4:2411–2418

    PubMed  Google Scholar 

  20. Matthias C, Jahnke V, Jones PW, Hoban PR, Alldersea J, Worrall S, Anthony A, Fryer AA, Strange RC (1999) Cyclin D1, glutathione S-transferase and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomarkers 8:815–823

    Google Scholar 

  21. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of 47 operable squamous cell carcinomas of the head and neck. Cancer Res 55:975–978

    PubMed  Google Scholar 

  22. Mielcarek-Kuchta D, Olofsson J, Golusinski W (2003) p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 260:549–554

    Article  PubMed  Google Scholar 

  23. Morgan DO (1995) Principles of CDK regulation. Nature 374:131–134

    Article  PubMed  Google Scholar 

  24. Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, Simpson AJ, Caballero OL, Kowalski LP (2004) Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol 40:604–610

    Article  PubMed  Google Scholar 

  25. Pignatora L, Pruneri G, Carboni N, Capaccio P, Cesana BM, Neri A, Buffa R (1998) Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 16:3069–3077

    PubMed  Google Scholar 

  26. Porter TR, Richards FM, Houlston RS (2002) Contribution of cyclin D1(CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21:1928–1933

    Article  PubMed  Google Scholar 

  27. Qiuling S, Yuxin Z, Suhua Z, Cheng X, Shuguang L, Fengsheng H (2003) Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis 24:1499–1503

    Article  PubMed  Google Scholar 

  28. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559–1571

    PubMed  Google Scholar 

  29. Rogers S, Wells R, Rechsteiner M (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234:364–368

    PubMed  Google Scholar 

  30. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, Hara M, Saito I (1998) Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16:1701–1712

    Article  PubMed  Google Scholar 

  31. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes—a review. Gene (Amst) 159:83–96

    Google Scholar 

  32. Schuuring E, Verhoeven E, Mooi WJ, Michalides R (1992) Identification and cloning of two overexpressed genes, U21B31/PRAD and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355–361

    PubMed  Google Scholar 

  33. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Knudsen ES (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 8:30339–30347

    Article  Google Scholar 

  34. Wang L, Habuchi T, Takahashi T (2002) Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23:257–264

    Article  PubMed  Google Scholar 

  35. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671

    Article  PubMed  Google Scholar 

  36. Wang X, Pavelic ZP, Li Y-Q, Wang L, Gleich L, Radack K, Gluckman JL, Stambrook PJ (1995) Amplification and overexpressio of cyclin D1 gene in head and neck squamous cell carcinoma. J Clin Pathol Mol Pathol 48:256–259

    Google Scholar 

  37. Williams ME, Gaffey M J, Weiss LM, Wilczynski SP, Schuuring E, Levine PA (1993) Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 119:1238–1243

    PubMed  Google Scholar 

  38. Yu Q, Geng Y, Sicinski P (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature 28:1017–1021

    Article  Google Scholar 

  39. Zheng Y, Shen H, Sturgis EM (2001) Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22:1195–1199

    Article  PubMed  Google Scholar 

  40. Zhou P, Jiang W, Weghorst CM, Weinstein IB (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56:36–39

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Human Genetics, Polish Academy of Sciences, Ul. Strzeszyńska 32, 60-479, Poznan, Poland

    Malgorzata Rydzanicz & Krzysztof Szyfter

  2. Department of Otolaryngology, University School of Medical Sciences, Poznan, Poland

    Pawel Golusinski, Daniela Mielcarek-Kuchta, Wojciech Golusinski & Krzysztof Szyfter

Authors
  1. Malgorzata Rydzanicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pawel Golusinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela Mielcarek-Kuchta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wojciech Golusinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Krzysztof Szyfter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Malgorzata Rydzanicz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rydzanicz, M., Golusinski, P., Mielcarek-Kuchta, D. et al. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol 263, 43–48 (2006). https://doi.org/10.1007/s00405-005-0957-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-005-0957-7

Keywords

Search

Navigation